Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem
- PMID: 12581269
- DOI: 10.1046/j.1464-5491.2003.00860.x
Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem
Abstract
Aims: To determine if there has been a change in the prevalence of pathogenic organisms in foot ulcers in diabetic patients in 2001 compared with our previous study in 1998.
Methods: A retrospective analysis of wound swabs taken from infected foot ulcers in diabetic patients attending the outpatient clinic in the Manchester Foot Hospital over a twelve-month period. A total of 63 patients with positive wound swabs were identified.
Results: Gram-positive aerobic bacteria still predominate (84.2%) and the commonest single isolate remains Staphylococcus aureus (79.0%) which is higher than we previously reported. MRSA was isolated in 30.2% of the patients which is almost double the proportion of MRSA-affected patients three years ago. This did not appear to be related to prior antibiotic usage. There was no increase in hospitalisation because of MRSA infection.
Conclusions: The problem of MRSA continues to increase despite the precautions taken to prevent MRSA spread. There is a need for a multi-centre study looking into the prevalence of MRSA in diabetic foot ulcer and how this can be reduced in the diabetic foot clinic.
Similar articles
-
Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic.Diabet Med. 1999 Sep;16(9):767-71. doi: 10.1046/j.1464-5491.1999.00132.x. Diabet Med. 1999. PMID: 10510954
-
[Risk factors for infections of methicillin-resistant Staphylococci in diabetic foot patients].Zhonghua Yi Xue Za Zhi. 2012 Jan 31;92(4):228-31. Zhonghua Yi Xue Za Zhi. 2012. PMID: 22490791 Chinese.
-
Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers.Clin Microbiol Infect. 2006 Feb;12(2):186-9. doi: 10.1111/j.1469-0691.2005.01279.x. Clin Microbiol Infect. 2006. PMID: 16441460
-
Diabetic foot infections: microbiological aspects, current and future antibiotic therapy focusing on methicillin-resistant Staphylococcus aureus.Int Wound J. 2011 Dec;8(6):567-77. doi: 10.1111/j.1742-481X.2011.00849.x. Epub 2011 Aug 23. Int Wound J. 2011. PMID: 21883937 Free PMC article. Review.
-
Do diabetic foot infections with methicillin-resistant Staphylococcus aureus differ from those with other pathogens?Int J Low Extrem Wounds. 2014 Dec;13(4):263-72. doi: 10.1177/1534734614550311. Epub 2014 Oct 5. Int J Low Extrem Wounds. 2014. PMID: 25288579 Review.
Cited by
-
Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections.PLoS One. 2013;8(2):e56022. doi: 10.1371/journal.pone.0056022. Epub 2013 Feb 13. PLoS One. 2013. PMID: 23418497 Free PMC article.
-
Epidemiology of Methicillin-Resistant Staphylococcus aureus Diabetic Foot Infections in a Large Academic Hospital: Implications for Antimicrobial Stewardship.PLoS One. 2016 Aug 24;11(8):e0161658. doi: 10.1371/journal.pone.0161658. eCollection 2016. PLoS One. 2016. PMID: 27556897 Free PMC article.
-
Skin and soft tissue infections and associated complications among commercially insured patients aged 0-64 years with and without diabetes in the U.S.PLoS One. 2013 Apr 10;8(4):e60057. doi: 10.1371/journal.pone.0060057. Print 2013. PLoS One. 2013. PMID: 23593162 Free PMC article.
-
Diabetic foot infections: stepwise medical and surgical management.Int Wound J. 2004 Jun;1(2):123-32. doi: 10.1111/j.1742-4801.2004.00035.x. Int Wound J. 2004. PMID: 16722884 Free PMC article. Review.
-
Emerging Diabetic Foot Ulcer Microbiome Analysis Using Cutting Edge Technologies.J Diabetes Sci Technol. 2022 Mar;16(2):353-363. doi: 10.1177/1932296821990097. Epub 2021 Feb 12. J Diabetes Sci Technol. 2022. PMID: 33576276 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical